Bimiralisib
5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
Molecular Identity
Bimiralisib
5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
PubChem CID: 58507717
2D Structure
Properties
C17H20F3N7O2
Molecular Formula
411.40
Molecular Weight
g/mol
411.1631
Exact Mass
Da
1.3
XLogP
Drug-like (Lipinski: < 5)
103
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
12
H-Bond Acceptors
506
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Bimiralisib1225037-39-7PQR309PI3K-IN-2PQR-309NCB56Z3QHB00LBNC-B52-Pyridinamine, 5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)-5-[bis(morpholin-4-yl)-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-aminebimiralisibum5-(bis(morpholin-4-yl)-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amineRefChem:10798715-(4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Bimiralisib
Loading drug network...